Physician profile
Alejandro Aquino
NPI 1669628012
$5,490.80
in general payments reported to CMS, 2019-2025
21 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,668 · 2020: $821 · 2021: $752 · 2022: $339 · 2023: $525 · 2024: $145 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $910.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,203.14 | 2019-2023 | Watchman Access System |
| Abbott Laboratories | $1,175.89 | 2019-2025 | Coroflow, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Medtronic Vascular, INC. | $1,086.39 | 2019 | |
| Abiomed | $713.20 | 2019-2023 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $280.41 | 2019-2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $245.86 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $144.01 | 2019 | |
| Cardiovascular Systems INC. | $88.94 | 2019-2022 | |
| Becton, Dickinson and Company | $85.74 | 2025 | Hemosphere |
| Amgen INC. | $84.97 | 2020-2021 | |
| Medtronic, INC. | $80.73 | 2021-2025 | Vitalflow Console, Onyx Frontier, Hawkone |
| Edwards Lifesciences Corporation | $75.67 | 2024-2025 | Hemosphere, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $48.25 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $46.14 | 2024-2025 | |
| Inari Medical, INC. | $33.15 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.32 | 2019 | |
| Stryker Corporation | $18.76 | 2025 | Flowtriever |
| Chiesi USA, INC. | $17.77 | 2019 | |
| Teleflex LLC | $16.65 | 2023 | Guideliner |
| Kowa Pharmaceuticals America, INC. | $14.17 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Aquino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.